BRCA1 and breast carcinoma: Indeed, the positive effect of BRCA1 deficit on Xa XIST expression is demonstrated in vitro by BRCA1 silencing in XCI-type 2 (Xi negative/XIST positive) MCF7 breast cancer cell line, which leads to a significant increase of XIST levels and promoter demethylation.